• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.基因组免疫逃逸:头颈部鳞状细胞癌的诊断与治疗机遇
J Clin Med. 2022 Dec 7;11(24):7259. doi: 10.3390/jcm11247259.
2
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.头颈部鳞状细胞癌:免疫调节癌症治疗的基因组学和新兴生物标志物。
Semin Cancer Biol. 2018 Oct;52(Pt 2):228-240. doi: 10.1016/j.semcancer.2018.01.008. Epub 2018 Jan 31.
3
Correlate the Mutation and the Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer.对头颈部鳞状细胞癌中的突变以及突变与免疫特征进行关联分析。
Comput Struct Biotechnol J. 2019 Jul 26;17:1020-1030. doi: 10.1016/j.csbj.2019.07.009. eCollection 2019.
4
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.包含或缺乏转录活性人乳头瘤病毒的头颈癌中的遗传模式
J Natl Cancer Inst. 2004 Jul 7;96(13):998-1006. doi: 10.1093/jnci/djh183.
5
Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.人乳头瘤病毒和 p53 突变与日本人群头颈部鳞状细胞癌的关系。
Cancer Sci. 2014 Apr;105(4):409-17. doi: 10.1111/cas.12369. Epub 2014 Mar 30.
6
Head and Neck Squamous Cell Cancer: Approach to Staging and Surveillance头颈部鳞状细胞癌:分期与监测方法
7
Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.生物信息学分析鉴定出 HPV 相关的头颈部鳞状细胞癌肿瘤微环境重塑的预后生物标志物。
Front Cell Infect Microbiol. 2022 Nov 8;12:1007950. doi: 10.3389/fcimb.2022.1007950. eCollection 2022.
8
An updated overview of HPV-associated head and neck carcinomas.人乳头瘤病毒相关头颈癌的最新综述。
Oncotarget. 2014 Jun 30;5(12):3956-69. doi: 10.18632/oncotarget.1934.
9
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations.全基因组分析头颈部鳞状细胞癌揭示 HPV、TP53、吸烟和酒精相关等位基因获得性单亲二体性基因组改变。
Neoplasia. 2019 Feb;21(2):197-205. doi: 10.1016/j.neo.2018.12.002. Epub 2019 Jan 4.
10
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.性别、种族和人乳头瘤病毒在口咽和非口咽头颈鳞状细胞癌中的预后作用。
Cancer. 2017 May 1;123(9):1566-1575. doi: 10.1002/cncr.30353. Epub 2017 Feb 27.

引用本文的文献

1
Immune Evasion in Head and Neck Squamous Cell Carcinoma: Roles of Cancer-Associated Fibroblasts, Immune Checkpoints, and Mutations in the Tumor Microenvironment.头颈部鳞状细胞癌中的免疫逃逸:肿瘤相关成纤维细胞、免疫检查点及肿瘤微环境中突变的作用
Cancers (Basel). 2025 Aug 7;17(15):2590. doi: 10.3390/cancers17152590.
2
Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities.乳腺癌中影响HLA基因的杂合性缺失(LOH):临床相关性与治疗机遇
Genes (Basel). 2024 Nov 28;15(12):1542. doi: 10.3390/genes15121542.
3
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.表皮生长因子受体抑制剂对 PI3K/Akt/mTOR 活性的差异调节:顺铂耐药头颈部鳞状细胞癌中共同靶向 EGFR 和 PI3K 的原理。
Head Neck. 2024 May;46(5):1126-1135. doi: 10.1002/hed.27718. Epub 2024 Mar 1.
4
Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.PRI-724 Wnt/β-连环蛋白通路抑制剂与维莫德吉、厄洛替尼或 HS-173 联合抑制头颈部鳞状癌细胞。
Int J Mol Sci. 2023 Jun 21;24(13):10448. doi: 10.3390/ijms241310448.
5
Current Approach and Future Directions in the Diagnosis and Prognosis of Keratinocyte Carcinomas.角质形成细胞癌诊断与预后的当前方法及未来方向
J Clin Med. 2023 Jun 11;12(12):3974. doi: 10.3390/jcm12123974.

本文引用的文献

1
The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker.肿瘤芽生在口腔鳞状细胞癌中的新出现影响:一种新预后标志物的主要问题及临床相关性
Cancers (Basel). 2022 Jul 22;14(15):3571. doi: 10.3390/cancers14153571.
2
Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers.头颈部癌诱导化疗反应和毒性的预测生物标志物
Front Oncol. 2022 Jul 6;12:900903. doi: 10.3389/fonc.2022.900903. eCollection 2022.
3
The Promise of Circulating Tumor DNA in Head and Neck Cancer.循环肿瘤DNA在头颈癌中的前景
Cancers (Basel). 2022 Jun 16;14(12):2968. doi: 10.3390/cancers14122968.
4
The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas.免疫调节细胞因子在头颈部鳞状细胞癌肿瘤微环境中的作用
Cancers (Basel). 2022 Jun 11;14(12):2884. doi: 10.3390/cancers14122884.
5
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.头颈部鳞状细胞癌中的免疫检查点抑制剂:3期临床试验的系统评价
World J Clin Oncol. 2022 May 24;13(5):388-411. doi: 10.5306/wjco.v13.i5.388.
6
Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People.头颈癌患病率的性别差异:对1000万健康人群的10年随访研究。
Cancers (Basel). 2022 May 20;14(10):2521. doi: 10.3390/cancers14102521.
7
Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.食管癌及头颈部鳞状细胞癌的液体活检
Front Med (Lausanne). 2022 Apr 29;9:827297. doi: 10.3389/fmed.2022.827297. eCollection 2022.
8
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.头颈部癌症中 TP53 和 CDKN2A 突变谱与肿瘤突变负担的关联。
Clin Cancer Res. 2022 May 2;28(9):1925-1937. doi: 10.1158/1078-0432.CCR-21-4316.
9
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.帕博利珠单抗单药或联合化疗治疗复发/转移性头颈部鳞状细胞癌的 KEYNOTE-048 研究:程序性死亡配体-1 联合阳性评分的亚组分析。
J Clin Oncol. 2022 Jul 20;40(21):2321-2332. doi: 10.1200/JCO.21.02198. Epub 2022 Mar 25.
10
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.

基因组免疫逃逸:头颈部鳞状细胞癌的诊断与治疗机遇

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.

作者信息

Kirtane Kedar, St John Maie, Fuentes-Bayne Harry, Patel Sandip P, Mardiros Armen, Xu Han, Ng Eric W, Go William Y, Wong Deborah J, Sunwoo John B, Welch John S

机构信息

Moffitt Cancer Center, Tampa, FL 33612, USA.

Otolaryngology, UCLA School of Medicine, Los Angeles, CA 90095, USA.

出版信息

J Clin Med. 2022 Dec 7;11(24):7259. doi: 10.3390/jcm11247259.

DOI:10.3390/jcm11247259
PMID:36555876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9781632/
Abstract

Head and neck squamous cell cancers (HNSCCs) represent a diverse group of tumors emerging within different mucosal surfaces of the oral cavity, nasopharynx, oropharynx, larynx, and hypopharynx. HNSCCs share common clinical risk factors and genomic features, including smoking, alcohol, age, male sex, aneuploidy, and mutations. Viral initiating and contributing events are increasingly recognized in HNSCCs. While both Epstein-Barr Virus (EBV) and human papilloma virus (HPV) are observed, EBV is more frequently associated with nasopharyngeal cancers whereas HPV is associated with oropharyngeal cancers. HNSCCs are associated with high tumor mutational burden and loss of tumor suppressor gene function, especially in and X-linked genes. Multiple lines of evidence suggest that HNSCCs are subject to immunologic surveillance and immune-induced evolutionary pressure that correlate with negative clinical outcomes. This review will discuss genomic mechanisms related to immune-mediated pressures and propose prognostic and therapeutic implications of detectable immune escape mechanisms that drive tumorigenesis and disease progression.

摘要

头颈部鳞状细胞癌(HNSCC)是一类起源于口腔、鼻咽、口咽、喉和下咽不同黏膜表面的肿瘤。HNSCC具有共同的临床风险因素和基因组特征,包括吸烟、饮酒、年龄、男性、非整倍体和突变。病毒引发和促成事件在HNSCC中越来越受到认可。虽然EB病毒(EBV)和人乳头瘤病毒(HPV)都有发现,但EBV更常与鼻咽癌相关,而HPV与口咽癌相关。HNSCC与高肿瘤突变负担和肿瘤抑制基因功能丧失有关,尤其是在常染色体和X连锁基因中。多条证据表明,HNSCC受到免疫监视和免疫诱导的进化压力,这与不良临床结果相关。本综述将讨论与免疫介导压力相关的基因组机制,并提出可检测到的免疫逃逸机制对肿瘤发生和疾病进展的预后及治疗意义。